Madrigal Pharmaceuticals Secures $500 Million in Senior Secured Credit From Blue Owl Managed Funds to Further Extend Leadership Position in MASH

Madrigal Pharmaceuticals Secures $500 Million in Senior Secured Credit from Blue Owl Managed Funds to Further Extend Leadership Position in MASH

Proceeds to primarily support MASH pipeline expansion and to refinance existing senior credit facility$350 million initial term loan funded at close and up to an additional $150 million available through 2027Agreement also provides for the possibility of additional incremental facilities of up to $250 million of credit to support further strategic pipeline expansion

Madrigal Pharmaceuticals Secures $500 Million Credit Facility to Expand MASH Pipeline

CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has secured a $500 million senior secured credit facility from funds managed by Blue Owl Capital (NYSE: OWL), strengthening its financial position as it seeks to expand its leadership in the treatment of metabolic dysfunction-associated steatohepatitis (MASH). The non-dilutive financing includes a $350 million term loan funded at closing, which was partially used to refinance the c…

Blue Owl Capital Extends up to $500 Million in Senior Secured Credit to Madrigal Pharmaceuticals // Cooley // Global Law Firm